Artículos por temáticas

Comparison of contralateral pallidotomy vs. pallidal stimulation after prior unilateral pallidotomy for Parkinson's disease.

Hyam JA, Joint C, Green AL, Aziz TZ.

Neuromodulation. 2011 Mar-Apr;14(2):117-22; discussion 122. doi: 10.1111/j.1525-1403.2010.00318.x.

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.

van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE.

CNS Neurosci Ther. 2011 Oct;17(5):428-41. doi: 10.1111/j.1755-5949.2010.00166.x. Review.

Religious and spiritual beliefs in outpatients suffering from Parkinson Disease.

Giaquinto S, Bruti L, Dall'Armi V, Palma E, Spiridigliozzi C.

Int J Geriatr Psychiatry. 2011 Sep;26(9):916-22. doi: 10.1002/gps.2624.

Death-associated protein kinase 1 variation and Parkinson's disease.

Dachsel JC, Wider C, Vilariño-Güell C, Aasly JO, Rajput A, Rajput AH, Lynch T, Craig D, Krygowska-Wajs A, Jasinska-Myga B, Opala G, Barcikowska M, Czyzewski K, Wu RM, Heckman MG, Uitti RJ, Wszolek ZK,

Eur J Neurol. 2011 Aug;18(8):1090-3. doi: 10.1111/j.1468-1331.2010.03255.x.

Pathology of vessels supplying the brain in patients with Parkinson's disease.

Ivan R, Irena R.

Mov Disord. 2011 Jun;26(7):1363; author reply 1363-4. doi: 10.1002/mds.23444. No abstract available.

Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.

Watanabe M, Takeda T, Nakamagoe K, Tamaoka A.

Eur J Neurol. 2011 Jul;18(7):1010-3. doi: 10.1111/j.1468-1331.2010.03211.x.

Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease.

Piallat B, Polosan M, Fraix V, Goetz L, David O, Fenoy A, Torres N, Quesada JL, Seigneuret E, Pollak P, Krack P, Bougerol T, Benabid AL, Chabardès S.

Ann Neurol. 2011 May;69(5):793-802. doi: 10.1002/ana.22222.

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease.

Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann Gross R, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Van Deerlin VM, Lee VM, Soares H, Trojanowski JQ.

Ann Neurol. 2011 Apr;69(4):655-63. doi: 10.1002/ana.22271.

Instability of syllable repetition in Parkinson's disease--influence of levodopa and deep brain stimulation.

Skodda S, Flasskamp A, Schlegel U.

Mov Disord. 2011 Mar;26(4):728-30. doi: 10.1002/mds.23439.

Fear of falling and falls in people with Parkinson's disease treated with deep brain stimulation in the subthalamic nuclei.

Nilsson MH, Rehncrona S, Jarnlo GB.

Acta Neurol Scand. 2011 Jun;123(6):424-9. doi: 10.1111/j.1600-0404.2010.01418.x.

Facilitated temporal summation of pain at spinal level in Parkinson's disease.

Perrotta A, Sandrini G, Serrao M, Buscone S, Tassorelli C, Tinazzi M, Zangaglia R, Pacchetti C, Bartolo M, Pierelli F, Martignoni E.

Mov Disord. 2011 Feb 15;26(3):442-8. doi: 10.1002/mds.23458.

Focal cortical and subcortical atrophy in early Parkinson's disease.

Tinaz S, Courtney MG, Stern CE.

Mov Disord. 2011 Feb 15;26(3):436-41. doi: 10.1002/mds.23453.

Targeting dopa-sensitive and dopa-resistant gait dysfunction in Parkinson's disease: selective responses to internal and external cues.

Rochester L, Baker K, Nieuwboer A, Burn D.

Mov Disord. 2011 Feb 15;26(3):430-5. doi: 10.1002/mds.23450.

The most cited works in Parkinson's disease.

Ponce FA, Lozano AM.

Mov Disord. 2011 Feb 15;26(3):380-90. doi: 10.1002/mds.23445. Review.

Color vision in Parkinson's disease and essential tremor.

Oh YS, Kim JS, Chung SW, Song IU, Kim YD, Kim YI, Lee KS.

Eur J Neurol. 2011 Apr;18(4):577-83. doi: 10.1111/j.1468-1331.2010.03206.x.